Oculis Holdingの空売り状況は、投資家がOculis Holdingの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Oculis Holding (NASDAQ:OCS) 株価情報, 空売り情報

Oculis Holding

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Oculis Holding AG

Oaktree Specialty Lending Corporation - Closed End Fund

Oaktree Specialty Lending Corp

<p>The <strong>Travelers Companies, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) announced Tuesday that it expects $1.7 billion in pretax catastrophe losses from the California wildfires that swept through the state in January. After taxes, the estimated <a href="https://www.benzinga.com/quote/TRV/news">loss amounts to $1.3 billion</a>.</p>
<p>The insurer said the estimate includes losses from its personal and commercial segments, as well as assessments from the California FAIR Plan, the state's insurer of last resort. Recoveries from reinsurance have been factored into the estimate.</p>
<p>Analysts have projected that total industry losses from the wildfires could reach $30 billion. Other insurers are also reporting significant impacts. Last week, Allstate said it expects about $1.1 billion in pretax catastrophe losses from the fires, net of reinsurance.</p>
<p>Travelers&#8217; announcement follows a challenging period for insurers operating in California, where wildfire risk has led several companies to scale back coverage or raise premiums. The FAIR Plan, which provides limited fire insurance for homeowners unable to get coverage elsewhere, can require insurers to help fund claims.</p>
<p>Travelers said it is actively working to process claims and assist affected policyholders. CEO <strong>Alan Schnitzer</strong> acknowledged the scale of the disaster, noting the company&#8217;s commitment to supporting customers and communities impacted by the fires.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/trading-ideas/technicals/25/02/43636110/stock-of-the-day-does-classic-head-shoulders-pattern-mean-snap-goes-lower">Stock Of The Day: Does Classic Head &amp; Shoulders Pattern Mean Snap Goes Lower?</a></strong></li>
</ul>
<p><em>Image Via Shutterstock.</em></p>


News

Movers

Travelers Expects $1.7 Billion In Catastrophe Losses From California Wildfires

<p>Cryptocurrency markets are trading lower on Tuesday, with Bitcoin tapping the $95,000 level.  </p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
<td><strong>Gains +/-</strong></td>
</tr>
<tr>
<td><strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$95,189.97</td>
<td>-2.3%</td>
</tr>
<tr>
<td><strong>Ethereum</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,600.05</td>
<td>-2.8%</td>
</tr>
<tr>
<td><strong>Solana</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$196.61</td>
<td>-2.8%</td>
</tr>
<tr>
<td><strong>XRP </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.40</td>
<td>-1%</td>
</tr>
<tr>
<td><strong>Dogecoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.2519</td>
<td>-0.7%</td>
</tr>
<tr>
<td><strong>Shiba Inu</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001559&nbsp;&nbsp;</td>
<td>-1.5%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Notable Statistics:</strong></p>
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 52.2% and daily active addresses growing by 20.2%. Transactions greater than $100,000 are up from 7,194 to 9,866 in a single day. Exchanges netflows are down by 137.2%.</li>
<li>Coinglass data reports 121,611 traders were liquidated in the past 24 hours for $217.83 million.</li>
<li>Martinez <a href="https://x.com/ali_charts/status/1889378618901668006">noted</a> that whales recently realized almost $800 million in BTC profits.</li>
</ul>
<p><strong>Notable Developments:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43618900/apple-vs-ibit-bitcoin-etf-one-is-warren-buffetts-berkshire-hathaways-biggest-holding-the-other-gives-exposure-to-a-crypto-he-vehemently-dislikes-which-has-generated-better-yearly-returns">Apple Vs IBIT Bitcoin ETF: One Is Warren Buffett&#8217;s Berkshire Hathaway&#8217;s Biggest Holding, The Other Gives Exposure To A Crypto He Vehemently Dislikes, Which Has Generated Better Yearly Returns?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43632945/bitcoin-solana-rise-in-january-but-ethereum-lagging-jpmorgan">Bitcoin, Solana Rise In January, But Ethereum Lagging: JPMorgan</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43622299/poland-rejects-bitcoin-reserves-as-czech-republic-and-us-explore-crypto-holdings">Poland Rejects Bitcoin Reserves As Czech Republic And US Explore Crypto Holdings</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43614251/hacker-pleads-guilty-to-secs-fake-bitcoin-etf-post-on-x-that-triggered-financial-wipeout-worth-millions">Hacker Pleads Guilty To SEC&#8217;s Fake Bitcoin ETF Post On X That Triggered Financial Wipeout Worth Millions</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43624201/ranking-the-xrp-dogecoin-solana-litecoin-etf-approval-chances-one-altcoin-has-a-90-chance-bloomberg-analyst-says">Ranking The XRP, Dogecoin, Solana, Litecoin ETF Approval Chances: One Altcoin Has A 90% Chance, Bloomberg Analyst Says</a></li>
</ul>
<p><strong>Top Losers:</strong></p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
<td><strong>Gains +/-</strong></td>
</tr>
<tr>
<td><strong>Onyxcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">XCN</a>)</td>
<td>&nbsp;$0.02132</td>
<td>-10.8%</td>
</tr>
<tr>
<td><strong>Ethena</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">ENA</a>)</td>
<td>&nbsp;$0.4441</td>
<td>-8.3%</td>
</tr>
<tr>
<td><strong>Aptos</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">APT</a>)</td>
<td>&nbsp;$5.87</td>
<td>-5.4%</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Trader Notes: </strong>With Bitcoin prices falling, crypto trader Altcoin Sherpa anticipates one final move down before recovery, expecting altcoins to retest previous lows while maintaining a relative bottom.</p>
<p> He remains flat on active positions but plans to bid the next dip, particularly in AI coins like ARC.</p>
<p> He also highlights the 100-day EMA approaching and expects the wick to be filled.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">1 final move down for <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> before the recovery imo. Alts prob test near those lows they made before but I still think &#x2A;relative&#x2A; bottom is in. Flat on active positions but looking to bid this next move down for AI coins like arc. <br /><br />100d EMA coming up + wick usually gets filled <a href="https://t.co/jimsBVCZwi">pic.twitter.com/jimsBVCZwi</a></p>
<p>&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1889396689590435954?ref_src=twsrc%5Etfw">February 11, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>Meanwhile, CrediBULL Crypto <a href="https://x.com/CredibleCrypto/status/1889400972482617668">notes</a> that Bitcoin is holding its higher timeframe (HTF) support zone, expecting continued consolidation as long as it holds. </p>
<p>He anticipates a dip below $94,100, a reclaim, and a push to local supply above recent highs, but remains cautious, saying, &#8220;Let&#8217;s see how things develop.&#8221;</p>
<p>Crypto analyst Ali Martinez reaffirmed his earlier outlook, warning that Bitcoin, XRP, Solana and Cardano could see a brief pullback. The TD Sequential indicator is flashing a sell signal on hourly charts.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">told y&#39;all! <a href="https://t.co/YaJ1gUNpWQ">https://t.co/YaJ1gUNpWQ</a></p>
<p>&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1889311239630663829?ref_src=twsrc%5Etfw">February 11, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43627642/the-bitcoin-4-year-cycle-is-dead-analyst-says-adapt-or-die">The Bitcoin 4-Year Cycle Is Dead, Analyst Says: &#8216;Adapt Or Die&#8217;</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$APT

$BTC

$DOGE

$ENA

$ETH

$SHIB

$SOL

$XCN

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Slide Lower: 'Final Move Down Before The Recovery,' Trader Says

<p><strong>Goldman Sachs</strong> downgraded <strong>Regenxbio Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>), citing gene therapy&#8217;s appeal for wet AMD and diabetic retinopathy is uncertain, as most patients are elderly and newer anti-VEGF treatments offer longer-<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39234044/goldman-sachs-optimistic-about-regenxbios-gene-therapy-pipeline-sees-over-160-upsid" rel="noreferrer noopener">lasting effects at lower costs</a>.</p>
<p>Analyst Paul Choi writes that <strong>AbbVie Inc</strong> partnered ABBV-RGX-314 faces growing competition, with its invasive delivery method making it less favorable than rival treatments.</p>
<p>Data from the ATMOSPHERE&nbsp;and ASCENT&nbsp;pivotal trials evaluating the safety and efficacy of the subretinal delivery of ABBV-RGX-314 in patients with Wet Age-Related Macular Degeneration (wet AMD) are expected in 2026.</p>
<p>AbbVie and REGENXBIO will plan a Phase 3 clinical program for ABBV-RGX-314 in&nbsp;Diabetic Retinopathy with <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n42944040/abbvie-and-regenxbio-announce-updates-on-the-abbv-rgx-314-clinical-program" rel="noreferrer noopener">suprachoroidal delivery</a>.</p>
<p>The analyst downgraded Regenxbio to Neutral from Buy and reduced the price forecast <a href="https://www.benzinga.com/quote/RGNX/analyst-ratings" target="_blank" rel="noreferrer noopener">to $14 from $38 prior</a>.</p>
<p>Goldman Sachs writes that additional competing treatments are progressing in the clinic, including <strong>EyePoint Pharmaceuticals</strong> <strong>Inc.&#8217;s </strong>Duravyu (vorolanib intravitreal insert), for which the company recently presented <a href="https://www.benzinga.com/pressreleases/25/02/g43490361/eyepoint-announces-positive-six-month-results-for-the-phase-2-verona-clinical-trial-of-duravyu-for" target="_blank" rel="noreferrer noopener">topline 6-month results</a>.</p>
<p>The analyst views the appeal of gene therapies in retinal disease overall as decreasing, thus reducing the assumed share of patients who are likely to opt for these treatments. This, in turn, leads to meaningfully lowering projected peak sales for ABBV-RGX-314.</p>
<p>As more people adopt the treatment, the analyst expects prices to keep declining despite changes in the ASP+ system. Ultimately, this could set a lower price benchmark for ABBV-RGX-314 as it nears commercialization.</p>
<p>Separately, the analyst highlights the increasing use of <strong>Regeneron</strong> <strong>Pharmaceutical Inc&#8217;s</strong> 2 mg Eylea biosimilars, which have taken share from the branded version despite the availability of Eylea HD.</p>
<p>Goldman analyst Choi finds the current data on RGX-202 (gene therapy for Duchenne muscular dystrophy) <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42033036/regenxbio-initiates-pivotal-phase-of-affinity-duchenne-trial-of-rgx-202-gene-therapy-and-reports-p" rel="noreferrer noopener">promising but limited</a>. Choi also sees a growing need for better treatments, citing interest in <strong>Sarepta Theraputics Inc&#8217;s</strong> Elevidys and strong enrollment in <strong>Edgewise Therapeutics&#8217; </strong>FOX study for post-gene therapy care.</p>
<p>Last month, Regenxbio and Nippon Shinyaku announced a strategic partnership to develop and commercialize RGX-121 for Mucopolysaccharidosis II, also known as Hunter syndrome, and RGX-111 for Mucopolysaccharidosis I, also <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n42967827/regenxbio-and-nippon-shinyaku-announce-exclusive-partnership-to-develop-and-commercialize-rgx-121-" rel="noreferrer noopener">known as Hurler syndrome</a>.</p>
<p>Regenxbio will receive&nbsp;$110 million&nbsp;and up to an additional&nbsp;$700 million&nbsp;if certain milestones are achieved, consisting of&nbsp;$40 million&nbsp;in potential development and regulatory milestones and&nbsp;$660 million&nbsp;in potential sales milestones.</p>
<p><strong>Price Action:</strong> RGNX stock is down 7.29% at $7.315 at last check Tuesday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/02/43629604/kelloggs-q4-earnings-beat-expectations-despite-challenging-market-conditions" target="_blank" rel="noreferrer noopener">WK Kellogg Q4: EPS Beat, Sales Miss Amid Challenging Market Conditions</a></strong></li>
</ul>
<p><em>Image via Shutterstock.</em></p>


Analyst Color

Biotech

Equities

Downgrades

Health Care

Price Target

Analyst Ratings

Trading Ideas

General

RGNX

Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Pfizer</strong>.</p>
<p>Looking at options history for Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) we detected 15 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish expectations and 26% with bearish.</p>
<p>From the overall spotted trades, 3 are puts, for a total amount of $345,963 and 12, calls, for a total amount of $1,524,951.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $30.0 for Pfizer over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Pfizer's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale trades within a strike price range from $20.0 to $30.0 in the last 30 days. </p>
<h3>Pfizer Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304945_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$0.98</td>
<td>$0.93</td>
<td>$0.98</td>
<td>$25.00</td>
<td>$245.0K</td>
<td>5.8K</td>
<td>2.5K</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$0.98</td>
<td>$0.98</td>
<td>$0.98</td>
<td>$25.00</td>
<td>$232.7K</td>
<td>5.8K</td>
<td>2.4K</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$1.6</td>
<td>$1.53</td>
<td>$1.53</td>
<td>$25.00</td>
<td>$229.5K</td>
<td>4.4K</td>
<td>13</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$1.0</td>
<td>$0.85</td>
<td>$1.0</td>
<td>$25.00</td>
<td>$217.7K</td>
<td>5.8K</td>
<td>9.6K</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$3.55</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$23.00</td>
<td>$175.5K</td>
<td>680</td>
<td>500</td>
</tr>
</tbody>
</table>
</p>
<h3>About Pfizer</h3>
<p>Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.</p>
<p>In light of the recent options history for Pfizer, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Current Position of Pfizer</h3>
<ul>
<li>Currently trading with a volume of 22,984,668, the PFE's price is down by -1.26%, now at $25.55. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 78 days.</li>
</ul>
<h3>What The Experts Say On Pfizer</h3>
<p>In the last month, 2 experts released ratings on this stock with an average target price of $31.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Guggenheim downgraded its action to Buy with a price target of $33.<br />
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Neutral rating on Pfizer with a target price of $29. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Pfizer, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Pfizer's Options Frenzy: What You Need to Know

<p>Benzinga's options scanner has just identified more than 14 option transactions on Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>), with a cumulative value of $566,975. Concurrently, our algorithms picked up 8 puts, worth a total of 272,605.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $130.0 and $180.0 for Celestica, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Celestica's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Celestica's whale trades within a strike price range from $130.0 to $180.0 in the last 30 days. </p>
<h3>Celestica Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304940_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$8.6</td>
<td>$8.3</td>
<td>$8.6</td>
<td>$130.00</td>
<td>$199.5K</td>
<td>1.3K</td>
<td align="right">338</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.6</td>
<td>$6.5</td>
<td>$6.5</td>
<td>$180.00</td>
<td>$114.4K</td>
<td>361</td>
<td align="right">181</td>
</tr>
<tr>
<td>CLS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$58.0</td>
<td>$55.5</td>
<td>$55.5</td>
<td>$165.00</td>
<td>$44.4K</td>
<td>4</td>
<td align="right">8</td>
</tr>
<tr>
<td>CLS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$39.5</td>
<td>$39.0</td>
<td>$39.0</td>
<td>$150.00</td>
<td>$42.9K</td>
<td>11</td>
<td align="right">12</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$7.1</td>
<td>$6.3</td>
<td>$6.6</td>
<td>$180.00</td>
<td>$41.5K</td>
<td>361</td>
<td align="right">334</td>
</tr>
</tbody>
</table>
</p>
<h3>About Celestica</h3>
<p>Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity &amp; Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity &amp; Cloud Solutions segment.</p>
<h3>Celestica's Current Market Status</h3>
<ul>
<li>With a trading volume of 2,090,984, the price of CLS is down by -2.23%, reaching $127.32.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 71 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Celestica</h3>
<p>A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $136.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Celestica with a target price of $139.<br />
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Celestica with a target price of $140.<br />
&#x2A; An analyst from RBC Capital has decided to maintain their Outperform rating on Celestica, which currently sits at a price target of $160.<br />
&#x2A; Maintaining their stance, an analyst from TD Securities continues to hold a Buy rating for Celestica, targeting a price of $107. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Celestica, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


A Closer Look at Celestica's Options Market Dynamics

<p>Financial giants have made a conspicuous bullish move on Dollar Tree. Our analysis of options history for Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) revealed 13 unusual trades.</p>
<p>Delving into the details, we found 46% of traders were bullish, while 46% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $875,042, and 4 were calls, valued at $271,340.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $67.0 to $78.0 for Dollar Tree over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Dollar Tree options trades today is 2097.0 with a total volume of 39,395.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Dollar Tree's big money trades within a strike price range of $67.0 to $78.0 over the last 30 days.</p>
<h3>Dollar Tree 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304936_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DLTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$4.0</td>
<td>$3.45</td>
<td>$3.5</td>
<td>$71.00</td>
<td>$175.0K</td>
<td align="right">1</td>
<td>7.1K</td>
</tr>
<tr>
<td>DLTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$4.0</td>
<td>$3.4</td>
<td>$3.5</td>
<td>$71.00</td>
<td>$174.6K</td>
<td align="right">1</td>
<td>6.6K</td>
</tr>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$5.45</td>
<td>$2.28</td>
<td>$3.5</td>
<td>$76.00</td>
<td>$122.5K</td>
<td align="right">0</td>
<td>350</td>
</tr>
<tr>
<td>DLTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$3.95</td>
<td>$3.4</td>
<td>$3.45</td>
<td>$71.00</td>
<td>$103.5K</td>
<td align="right">1</td>
<td>8.1K</td>
</tr>
<tr>
<td>DLTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$3.95</td>
<td>$3.35</td>
<td>$3.45</td>
<td>$71.00</td>
<td>$103.5K</td>
<td align="right">1</td>
<td>7.8K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Dollar Tree</h3>
<p>Dollar Tree operates discount stores across the United States and Canada, with over 8,800 shops under its namesake banner and 7,700 under Family Dollar. About 47% of Dollar Tree's sales in fiscal 2023 were composed of consumables (including food, health and beauty, and cleaning products), around 45% from variety items (including toys and homewares), and over 5% from seasonal items. Dollar Tree sells most of its merchandise at the $1.25 price point and positions its stores in well-populated suburban markets. Conversely, Family Dollar primarily sells consumable merchandise (80% of the banner's sales) at prices below $10. About two thirds of Family Dollar's stores are in urban and suburban markets, with the remaining one third located in rural areas.</p>
<p>In light of the recent options history for Dollar Tree, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Dollar Tree</h3>
<ul>
<li>Currently trading with a volume of 831,027, the DLTR's price is down by -1.99%, now at $72.39. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 29 days.</li>
</ul>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Dollar Tree with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


DLTR

A Closer Look at Dollar Tree's Options Market Dynamics

<p>Alcoa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) has outperformed the market over the past 5 years by 6.14% on an annualized basis producing an average annual return of 18.56%. Currently, Alcoa has a market capitalization of $9.67 billion. </p>
<p><strong>Buying $1000 In AA:</strong> If an investor had bought $1000 of AA stock 5 years ago, it would be worth <strong>$2,389.27</strong> today based on a price of $37.44 for AA at the time of writing.</p>
<h3>Alcoa's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304921_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

<p><strong>Elon Musk</strong> <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43393680/elon-musks-father-launches-musk-it-meme-coin-to-fund-new-think-tank">once again caused a stir</a> in the crypto world by changing his X profile name to Harry Bōlz.  </p>
<p><strong>What Happened: </strong>Musk, widely known for teasing meme coin prices higher through his comments or reactions, yet again caused a new meme coin inception, sending the HARRYBOLZ token to a valuation of over $20 million in a single day. </p>
<p>Influencer account Teslaconomics quipped in reaction &#8220;Harry Bōlz is my favorite billionaire.&#8221;</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">Elon Musk is my favorite billionaire, I mean Harry Bōlz is my favorite billionaire <a href="https://t.co/v409U62fOv">pic.twitter.com/v409U62fOv</a></p>
<p>&mdash; Teslaconomics (@Teslaconomics) <a href="https://twitter.com/Teslaconomics/status/1889312700095701039?ref_src=twsrc%5Etfw">February 11, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>This isn't Musk's first rodeo with name-based crypto spikes. </p>
<p>In December 2024, a <a href="https://www.benzinga.com/24/12/42739155/elon-musk-changes-his-name-to-kekius-maximus-on-x-sending-to-memecoin-skyrocketing-over-600">name change to ‘Kekius Maximus'</a> sparked a 1,200% rally in, and the name Harry Bolz had been <a href="https://x.com/cb_doge/status/1645433771062333441?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1645433771062333441%7Ctwgr%5Eb1de954d074c6e98608c30e7fe5fd32df2a991fa%7Ctwcon%5Es1_&amp;ref_url=https%3A%2F%2Fcryptobriefing.com%2Fharry-boldz-meme-coins-frenzy%2F">used</a> earlier by Musk in April 2023.</p>
<p><strong>Wallet Activity:</strong></p>
<p>Known for massive profits on MELANIA ($8.9 million) and TRUMP ($3.2 million), a wallet titled &#8216;LeBron&#8217; <a href="https://x.com/lookonchain/status/1889284808054043060">bought</a> 128.8 million HARRYBOLZ for 25 SOL (around $4,807) just four days ago. It later sold 109.8 million for 3,649 SOL (approximately $737,000) and still holds 18.97 million ($277,000), securing a $1 million profit. The wallet does not have any known affiliation with<strong> LeBron James</strong>.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43393680/elon-musks-father-launches-musk-it-meme-coin-to-fund-new-think-tank">Elon Musk&#8217;s Father Launches &#8216;Musk It&#8217; Meme Coin To Fund New Think Tank</a></strong></p>
<p><strong>Why It Matters: </strong>Crypto trader Momin pointed out that the HarryBolz pump was fueled by traders jumping in after Musk's name change, with some cashing out for six-figure profits. </p>
<p>Momin warned that if you didn't get in early, it's now a "lose-lose" situation, as the trend is weak and fading fast.</p>
<p>His <a href="https://x.com/mominsaqib/status/1889283242437874047">advice</a>: "If you're still playing this game, toss peanuts at whatever Elon mentions." The meme coin trenches are heating up again.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43527893/bitcoin-ethereum-and-this-elon-musk-themed-meme-coin-trend-on-social-media-report">Bitcoin, Ethereum And This Elon Musk-Themed Meme Coin Trend On Social Media: Report</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Elon Musk Changes Username To 'Harry Bolz,' Sends Meme Coin Flying To The Delight Of 'Lebron' Wallet

<p><strong>Goldman Sachs</strong> downgraded <strong>Dynavax Technologies Corporation </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVAX#NASDAQ">DVAX</a>) reflecting updated views and recent competitive <a target="_blank" href="https://www.benzinga.com/quote/DVAX" rel="noreferrer noopener">dynamics for vaccines</a>.</p>
<p>Goldman Sachs analyst Paul Choi has downgraded Dynavax to Sell from Neutral and cut the <a target="_blank" href="https://www.benzinga.com/quote/DVAX/analyst-ratings" rel="noreferrer noopener">price target from $15 to $12</a>. He notes growing competition in the shingles vaccine market, which could reduce the potential value of the Z-1018 program and add uncertainty to its long-term revenue.</p>
<p>Potential convenience improvements come from <strong>GSK Plc's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) Shingrix with the company's pre-filled syringes, which have been accepted for review by <a target="_blank" href="https://www.benzinga.com/25/02/43492835/gsk-launches-share-buyback-of-around-25-billion-after-better-than-expected-q4-earnings-raises-long-term-annual-sales-forecast-to-over-50-billion" rel="noreferrer noopener">both the FDA and EMA</a> (U.S. decision expected by 20 June).</p>
<p>Dynavax is conducting a Phase 1/2 trial to evaluate the safety, tolerability, and immunogenicity of Z-1018 compared to GSK's Shingrix in 441 healthy adults aged 50 to 69.</p>
<p>Choi also points to uncertain demand for repeat hepatitis B vaccinations in the 2030s, which may impact Heplisav-B's outlook beyond its peak sales. Despite its market share gains, questions remain about the FDA and ACIP's regulatory stance on vaccines in the U.S.</p>
<p>Last month,&nbsp;Dynavax announced preliminary HEPLISAV-B net product revenue of&nbsp;$268 million&nbsp;for 2024, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n42945098/dynavax-announces-preliminary-unaudited-fourth-quarter-and-full-year-2024-financial-highlights" rel="noreferrer noopener">up 26% year-over-year</a>.</p>
<p>HEPLISAV-B net product revenue reached&nbsp;$71 million&nbsp;for the fourth quarter of 2024, up 39%.</p>
<p>In May 2024, the FDA issued a Complete Response Letter stating that the application did not provide sufficient data to fully evaluate the effectiveness or safety of a four-dose <a target="_blank" href="https://www.benzinga.com/general/biotech/24/05/38818397/fda-declines-to-approve-expanded-use-of-dynavaxs-hepatitis-b-vaccine-in-hemodialysis-patients" rel="noreferrer noopener">regimen of HEPLISAV-B</a>.&nbsp;</p>
<p>Dynavax is expected to report fourth-quarter earnings <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43548293/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-" rel="noreferrer noopener">on 20 February</a>.</p>
<p>As per data from Benzinga Pro, analysts estimate Q4 adjusted EPS of $0.04, with sales of $72.92 million.</p>
<p>Analysts forecast 2024 sales of $278.13 million and <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">adjusted EPS of $0.12</a>.</p>
<p><strong>Price Action:</strong> DVAX stock is down 4.13% at $12.66 at last check Tuesday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/02/43629227/nano-cap-lipella-pharmaceuticals-stock-jumps-on-positive-trial-data-in-patients-with-sore-mouth-membranes" target="_blank" rel="noreferrer noopener">Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes</a></strong></li>
</ul>


DVAX

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

WIIM

FDMT

4D Molecular Therapeutics shares are trading lower after Chardan Capital cut its price target on the stock from $39 to $30.

<p><strong>Goldman Sachs</strong> analyst Ronald Keung maintained a Buy on <strong>Alibaba Group Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) with a <a target="_blank" href="https://www.benzinga.com/quote/BABA/analyst-ratings" rel="noreferrer noopener">price target of $117</a>.</p>
<p>Keung noted Alibaba&#8217;s Qwen2.5 family continues to gain traction in Huggingface&#8217;s latest Open LLM Leaderboard.</p>
<p>The analyst noted that Alibaba&#8217;s recent share price outperformance versus the sector (since its Qwen2.5 model launches) has been potentially due to the leading benchmark performances of its latest Qwen2.5-Max.</p>
<p><strong><em>Also Read:</em></strong><em> <a target="_blank" href="https://www.benzinga.com/25/02/43631776/apple-teams-up-with-alibaba-for-ai-innovation-in-china-submits-ai-features-for-regulatory-approval" rel="noreferrer noopener">Apple&#8217;s AI Split: Chooses Alibaba For China And OpenAI For Everyone Else</a></em></p>
<p>Investor focus is likely on the value of Alibaba Cloud as China&#8217;s largest cloud hyperscaler, where he valued Alibaba Cloud at 3 times revenue versus <strong>Amazon.Com Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) <strong>Amazon Web Services</strong> at 7 times revenue.</p>
<p>The analyst expects a sequentially stronger core domestic eCommerce performance, which the appliance trade-in program will help, a software service fee boost, and continued acceleration in cloud revenue growth.</p>
<p>With Alibaba&#8217;s upcoming December quarter results, Keung forecasted group revenue growth of 7% and Alibaba Cloud revenue growth, which he expects to accelerate to 10% for the December 2024 quarter and 12% for the March 2025 quarter (from 7% in the September 2024 quarter).</p>
<p>The analyst expects an acceleration of cloud revenue growth across China cloud service providers (CSPs) in 2025E on increased revenue contribution from the margin-accretive generative AI-driven business.</p>
<p>Keung noted the continued progress of open-source models at competitive performance and costs versus closed-source, with the increasing availability of open-source models supported by global cloud service providers.</p>
<p>He noted increasingly agile Chinese models and significant improvement in computing cost efficiencies could drive further room for broader adoption, exploration, the proliferation of AI applications, and potential for global expansion for Chinese players, assuming Chinese companies can continue to tap computing power and chips.</p>
<p>However, Keung flagged a rise in competition between capital-rich internet giants versus affordable start-ups like Deep Seek in the model layer, given lowering barriers to entry, an ongoing shift from training to more inferencing, and ongoing geopolitical uncertainties.</p>
<p>Yet Keung remained positive on long-term AI computing demand growth as further lowering of training and inference costs could drive higher AI adoption.</p>
<p><strong>Price Action:</strong> BABA stock is up 1.99% at $113.53 at the last check on Tuesday.</p>
<p><strong>Also Read:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/emerging-markets/25/02/43619521/deepseek-impact-billionaire-david-tepper-bets-big-on-china-increases-stakes-in-alibaba-jd-com-and-pdd" target="_blank" rel="noreferrer noopener">DeepSeek Impact? Billionaire David Tepper Bets Big on China, Increases Stakes in Alibaba, JD.com, And PDD</a></strong></li>
</ul>
<p><em>Photo courtesy: Shutterstock</em></p>


Reiteration

Tech

AMZN

BABA

Alibaba Cloud's Growth Accelerates With AI, Analyst Weighs DeepSeek's Rising Competition

<p>8 analysts have expressed a variety of opinions on Gambling.com Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAMB#NASDAQ">GAMB</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $17.12, along with a high estimate of $21.00 and a low estimate of $14.00. Witnessing a positive shift, the current average has risen by 10.95% from the previous average price target of $15.43.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304063_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>A clear picture of Gambling.com Gr's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Hickey</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$18.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>David Katz</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Mike Hickey</td>
<td>Benchmark</td>
<td>Announces</td>
<td>Buy</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>David Katz</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$20.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Chad Beynon</td>
<td>Macquarie</td>
<td>Raises</td>
<td>Outperform</td>
<td>$16.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ryan Sigdahl</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$16.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jeffrey Stantial</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$14.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Barry Jonas</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$16.00</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Gambling.com Gr. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Gambling.com Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Gambling.com Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Gambling.com Gr's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/GAMB/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Gambling.com Gr analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Unveiling the Story Behind Gambling.com Gr</h2>
<p>Gambling.com Group Ltd is a multi-award-winning performance marketing company and a provider of digital marketing services in the online gambling industry. Its principal focus is on online casino and online sports betting and the fantasy sports industry. It generates revenue by referring online gamblers to online gambling operators.</p>
<h3>Breaking Down Gambling.com Gr's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Gambling.com Gr's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately <strong>36.92%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Communication Services sector.</p>
<p><strong>Net Margin:</strong> Gambling.com Gr's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>26.49%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Gambling.com Gr's ROE excels beyond industry benchmarks, reaching <strong>6.85%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Gambling.com Gr's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>4.68%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.24</strong>, Gambling.com Gr adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


GAMB

8 Analysts Have This To Say About Gambling.com Gr

<p>Across the recent three months, 4 analysts have shared their insights on Independence Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRT#NYSE">IRT</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $21.75, a high estimate of $23.00, and a low estimate of $21.00. Observing a 1.97% increase, the current average has risen from the previous average price target of $21.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304046_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>A comprehensive examination of how financial experts perceive Independence Realty Trust is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aaron Hecht</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$22.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$23.00</td>
<td>-</td>
</tr>
<tr>
<td>John Kim</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$21.00</td>
<td>$19.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Independence Realty Trust. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Independence Realty Trust compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Independence Realty Trust's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Independence Realty Trust's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/IRT/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Independence Realty Trust analyst ratings.</strong></a></p>
<h2>About Independence Realty Trust</h2>
<p>Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.</p>
<h3>Independence Realty Trust: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Independence Realty Trust faced challenges, resulting in a decline of approximately <strong>-5.02%</strong> in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.</p>
<p><strong>Net Margin:</strong> Independence Realty Trust's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>7.72%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Independence Realty Trust's ROE excels beyond industry benchmarks, reaching <strong>0.37%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Independence Realty Trust's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>0.21%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.68</strong>.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Expert Outlook: Independence Realty Trust Through The Eyes Of 4 Analysts

<p>In the last three months, 5 analysts have published ratings on Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $116.2, a high estimate of $141.00, and a low estimate of $85.00. A decline of 2.35% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304039_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>A clear picture of Baidu's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jiong Shao</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$95.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Fawne Jiang</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$130.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Alicia Yap</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$141.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>Shyam Patil</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$85.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Fawne Jiang</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$130.00</td>
<td>$135.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Baidu. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Baidu compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Baidu's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Baidu's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BIDU/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Baidu analyst ratings.</strong></a></p>
<h2>Get to Know Baidu Better</h2>
<p>Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.</p>
<h3>Financial Milestones: Baidu's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Baidu faced challenges, resulting in a decline of approximately <strong>-2.58%</strong> in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.</p>
<p><strong>Net Margin:</strong> Baidu's net margin excels beyond industry benchmarks, reaching <strong>22.74%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Baidu's ROE excels beyond industry benchmarks, reaching <strong>2.98%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Baidu's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.83%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.3</strong>.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BIDU

Analyst Expectations For Baidu's Future

<p>High-rolling investors have positioned themselves bullish on Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in HLT often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 11 options trades for Hilton Worldwide Holdings. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 45% bullish and 27% bearish. Among all the options we identified, there was one put, amounting to $32,060, and 10 calls, totaling $647,348.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $175.0 and $300.0 for Hilton Worldwide Holdings, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Hilton Worldwide Holdings's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hilton Worldwide Holdings's whale activity within a strike price range from $175.0 to $300.0 in the last 30 days. </p>
<h3>Hilton Worldwide Holdings Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304034_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>HLT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$87.5</td>
<td>$85.8</td>
<td>$87.5</td>
<td>$180.00</td>
<td>$175.0K</td>
<td align="right">0</td>
<td align="right">20</td>
</tr>
<tr>
<td>HLT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$95.0</td>
<td>$92.3</td>
<td>$94.0</td>
<td>$175.00</td>
<td>$94.0K</td>
<td align="right">0</td>
<td align="right">10</td>
</tr>
<tr>
<td>HLT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$88.0</td>
<td>$86.8</td>
<td>$88.0</td>
<td>$180.00</td>
<td>$70.4K</td>
<td align="right">0</td>
<td align="right">20</td>
</tr>
<tr>
<td>HLT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$88.9</td>
<td>$87.2</td>
<td>$88.0</td>
<td>$180.00</td>
<td>$61.6K</td>
<td align="right">0</td>
<td align="right">39</td>
</tr>
<tr>
<td>HLT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$11.9</td>
<td>$11.3</td>
<td>$11.79</td>
<td>$260.00</td>
<td>$46.9K</td>
<td align="right">387</td>
<td align="right">310</td>
</tr>
</tbody>
</table>
</p>
<h3>About Hilton Worldwide Holdings</h3>
<p>Hilton Worldwide Holdings operates more than 1.2 million rooms across its more than 20 brands serving the premium economy scale through luxury segments. Hampton and Hilton are the two largest brands, representing 28% and 19%, respectively, of the company's total rooms, as of Dec. 31, 2023. Recent brands launched over the last few years include Home2, Curio, Canopy, Spark, Tru, Tempo, and LivSmart, as well as a partnership with Small Luxury Hotels and acquisitions of Nomad and Graduate Hotels. Managed and franchised hotels represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.</p>
<p>After a thorough review of the options trading surrounding Hilton Worldwide Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Hilton Worldwide Holdings</h3>
<ul>
<li>Currently trading with a volume of 1,213,929, the HLT's price is up by 1.14%, now at $270.53. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 71 days.</li>
</ul>
<h3>Professional Analyst Ratings for Hilton Worldwide Holdings</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $264.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Macquarie continues to hold a Neutral rating for Hilton Worldwide Holdings, targeting a price of $260.<br />
&#x2A; An analyst from Mizuho has revised its rating downward to Neutral, adjusting the price target to $263.<br />
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Neutral rating for Hilton Worldwide Holdings, targeting a price of $272.<br />
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Hilton Worldwide Holdings, which currently sits at a price target of $287.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Hilton Worldwide Holdings, which currently sits at a price target of $240. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Hilton Worldwide Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


What the Options Market Tells Us About Hilton Worldwide Holdings

<p>Ratings for Spire Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $19.5, a high estimate of $24.00, and a low estimate of $16.00. Marking an increase of 65.96%, the current average surpasses the previous average price target of $11.75. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304030_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The perception of Spire Global by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Austin Moeller</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$24.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Austin Moeller</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$18.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Jeff Van Rhee</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$20.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$9.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Spire Global. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Spire Global compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Spire Global's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Spire Global's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SPIR/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Spire Global analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Delving into Spire Global's Background</h2>
<p>Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.</p>
<h3>Financial Insights: Spire Global</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Spire Global showcased positive performance, achieving a revenue growth rate of <strong>6.29%</strong> as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> Spire Global's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-98.32%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Spire Global's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-32.41%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Spire Global's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-9.81%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Spire Global's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>1.53</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SPIR

Spire Global Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Walt Disney</strong>.</p>
<p>Looking at options history for Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) we detected 35 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 51% of the investors opened trades with bullish expectations and 40% with bearish.</p>
<p>From the overall spotted trades, 19 are puts, for a total amount of $958,121 and 16, calls, for a total amount of $924,268.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $85.0 and $140.0 for Walt Disney, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Walt Disney options trades today is 1833.07 with a total volume of 6,753.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Walt Disney's big money trades within a strike price range of $85.0 to $140.0 over the last 30 days.</p>
<h3>Walt Disney Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304029_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.2</td>
<td>$9.0</td>
<td>$9.0</td>
<td>$115.00</td>
<td>$180.0K</td>
<td>5.4K</td>
<td align="right">239</td>
</tr>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$12.0</td>
<td>$11.85</td>
<td>$11.85</td>
<td>$115.00</td>
<td>$152.8K</td>
<td>732</td>
<td align="right">130</td>
</tr>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$5.25</td>
<td>$5.2</td>
<td>$5.2</td>
<td>$105.00</td>
<td>$118.3K</td>
<td>6.2K</td>
<td align="right">418</td>
</tr>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$13.0</td>
<td>$12.85</td>
<td>$12.9</td>
<td>$120.00</td>
<td>$92.8K</td>
<td>544</td>
<td align="right">100</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$26.4</td>
<td>$26.2</td>
<td>$26.2</td>
<td>$95.00</td>
<td>$83.8K</td>
<td>1.2K</td>
<td align="right">33</td>
</tr>
</tbody>
</table>
</p>
<h3>About Walt Disney</h3>
<p>The Walt Disney Co operates in three global business segments: entertainment, sports, and experiences. Entertainment and experiences both benefit from the firm's ownership of iconic franchises and characters. Entertainment includes the ABC broadcast network, several cable television networks, and the Disney+ and Hulu streaming services. Within the segment, Disney also engages in movie and television production and distribution, with content licensed to movie theaters, other content providers, or, increasingly, kept in-house for use on Disney's own streaming platform and television networks. The sports segment houses ESPN and the ESPN+ streaming service. Experiences contain Disney's theme parks and vacation destinations and also benefit from merchandise licensing.</p>
<p>In light of the recent options history for Walt Disney, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Walt Disney's Current Market Status</h3>
<ul>
<li>With a trading volume of 5,016,535, the price of DIS is down by -0.27%, reaching $108.99.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 84 days from now.</li>
</ul>
<h3>Expert Opinions on Walt Disney</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $130.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $130.<br />
&#x2A; In a cautious move, an analyst from Citigroup downgraded its rating to Buy, setting a price target of $125.<br />
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Walt Disney, maintaining a target price of $130.<br />
&#x2A; Maintaining their stance, an analyst from Rosenblatt continues to hold a Buy rating for Walt Disney, targeting a price of $135. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Walt Disney options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Check Out What Whales Are Doing With DIS

<p>Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) has outperformed the market over the past 15 years by 7.09% on an annualized basis producing an average annual return of 19.11%. Currently, Alphabet has a market capitalization of $2.27 trillion. </p>
<p><strong>Buying $1000 In GOOGL:</strong> If an investor had bought $1000 of GOOGL stock 15 years ago, it would be worth <strong>$13,691.99</strong> today based on a price of $185.14 for GOOGL at the time of writing.</p>
<h3>Alphabet's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304028_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


GOOGL

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

VEEE

Twin Vee PowerCats shares are trading higher. The stock may be moving on continued strength after announcing on Monday its acquisitions of BoatsForSale.com and YachtsForSale.com.

<p>Financial giants have made a conspicuous bullish move on CrowdStrike Holdings. Our analysis of options history for CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) revealed 75 unusual trades.</p>
<p>Delving into the details, we found 44% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 16 were puts, with a value of $994,933, and 59 were calls, valued at $4,260,826.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $180.0 to $630.0 for CrowdStrike Holdings over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in CrowdStrike Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to CrowdStrike Holdings's substantial trades, within a strike price spectrum from $180.0 to $630.0 over the preceding 30 days.</p>
<h3>CrowdStrike Holdings Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739304024_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$28.9</td>
<td>$28.15</td>
<td>$28.9</td>
<td>$450.00</td>
<td>$491.3K</td>
<td align="right">608</td>
<td align="right">499</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$46.95</td>
<td>$46.2</td>
<td>$46.5</td>
<td>$440.00</td>
<td>$446.4K</td>
<td align="right">462</td>
<td align="right">120</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$29.85</td>
<td>$29.3</td>
<td>$29.3</td>
<td>$450.00</td>
<td>$424.8K</td>
<td align="right">608</td>
<td align="right">329</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$46.65</td>
<td>$46.6</td>
<td>$46.65</td>
<td>$500.00</td>
<td>$223.9K</td>
<td align="right">529</td>
<td align="right">48</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$14.95</td>
<td>$15.85</td>
<td>$14.9</td>
<td>$420.00</td>
<td>$149.0K</td>
<td align="right">90</td>
<td align="right">102</td>
</tr>
</tbody>
</table>
</p>
<h3>About CrowdStrike Holdings</h3>
<p>CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.</p>
<p>Having examined the options trading patterns of CrowdStrike Holdings, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of CrowdStrike Holdings</h3>
<ul>
<li>Trading volume stands at 1,484,276, with CRWD's price up by 1.02%, positioned at $433.28.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 21 days.</li>
</ul>
<h3>Professional Analyst Ratings for CrowdStrike Holdings</h3>
<p>Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $425.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on CrowdStrike Holdings, which currently sits at a price target of $420.<br />
&#x2A; Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on CrowdStrike Holdings with a target price of $480.<br />
&#x2A; An analyst from Scotiabank has decided to maintain their Sector Perform rating on CrowdStrike Holdings, which currently sits at a price target of $370.<br />
&#x2A; Reflecting concerns, an analyst from Baird lowers its rating to Neutral with a new price target of $430.</p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for CrowdStrike Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


CRWD

Spotlight on CrowdStrike Holdings: Analyzing the Surge in Options Activity

In a report released today, Jason Gerberry from Bank of America Securities maintained a Buy rating on Oculis Holding (OCS – Research Report). The c...

Bank of America Securities Sticks to Its Buy Rating for Oculis Holding (OCS)

Oculis ($OCS), a global biopharmaceutical company dedicated to eye care treatments, recently reported disappointing results for the most recent qua...

Oculis Holding (OCS): A Biopharma Opportunity for Adventurous Investors

Bank of America Securities Sticks to Their Buy Rating for Oculis Holding (OCS)

Analyst Yi Chen from H.C. Wainwright reiterated a Buy rating on Oculis Holding (OCS – Research Report) and keeping the price target at $30.00. Yi C...

Oculis Holding's OCS-05 Receives Buy Rating Amid Promising Clinical Data and Regulatory Advancements

Oculis Holding ( ($OCS) ) has issued an update. Oculis Holding has announced positive results from a Phase 2 trial for OCS-05, a potential first-in...

Oculis Holding's OCS-05 Shows Promising Results in Phase 2 Trial for Acute Optic Neuritis

BofA raised the firm's price target on Oculis (OCS) to $31 from $23 and keeps a Buy rating on the shares. The company reported Phase 2 results from...

Oculis price target raised to $31 from $23 at BofA

Oculis Holding (OCS) has received a new Buy rating, initiated by Stifel Nicolaus analyst, Annabel Samimy. Annabel Samimy has given her Buy rating d...

Promising Clinical Results and Market Potential Drive Buy Rating for Oculis Holding

Catalyst Watch: Netflix earnings, Monster Beverage event, drug data, and quantum volatility

President Trump temporarily halts leasing and permitting for wind energy projects

Oculis Is An Interesting Growth Bet On Non-Invasive Eye Care

ACCD

AGEN

ALTR

ALXO

ARLUF

CANF

CELH

COST

DNNGY

DXST

ENGIY

FBGL

FTNT

GLXZ

GMVHF

INKT

INTU

ISRG

ITCI

JSPR

KURA

MMYT

MNST

MSTR

MVRK

NFLX

OCSAW

QBTS

RGTI

RWEOY

SIEGY

SLXN

SMEGF

SMPL

SSNLF

TOPP

TSX:VG

TWLO

VWDRY

Earnings

Press Releases

Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update

Oculis to Present at Upcoming September Investor Conferences

Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award

Management

Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

Oculis' DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024

Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees

Oculis Reports Q3 2024 Financial Results and Provides Company Updates

Oculis to Present at the Stifel 2024 Healthcare Conference

Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy

Comments

Oculis Holding

空売り

Oculis Holding (NASDAQ:OCS) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル